Chemours Company (The) ($CC) Stock Forecast: Up 5.5% Today

What is Chemours Company (The)?

Chemours Co (CC) specializes in titanium technologies, fluoroproducts, and chemical solutions. The stock reached a 52-week high of $27.53 today.

Why is Chemours Company (The) going up?

CC stock is up 5.5% on May 5, 2026 16:06

• CC stock hit a new 52-week high of $27.53, marking a significant 130% year-to-date increase, driven by strong investor confidence and strategic growth measures.
• The successful $700 million debt issuance to retire existing notes and positive analyst projections regarding enhanced profitability and higher titanium dioxide EBITDA margins have further propelled the optimistic sentiment.
• Despite concerns raised about potential overvaluation, positive market sentiment, approval of equity plans by shareholders, and the appointment of an independent auditor have all played a role in the stock's upward trend.
• Strategic decisions, such as the endorsement of the 2026 Equity and Incentive Plan and favorable analyst reviews, are likely factors boosting investor confidence and contributing to the positive momentum in CC stock.

CC Price Chart

CC Technical Analysis

CC News

Chemours Co stock hits 52-week high at 27.53 USD By Investing.com

Chemours Co (CC) stock has reached a new 52-week high of $27.53, reflecting a 130% year-to-date return, though InvestingPro's Fair Value analysis suggests it may be overvalued. The company recently completed a $700 million debt offering to redeem existing notes and analysts foresee improved profitability and increased titanium dioxide EBITDA margins.

https://au.investing.com/news/company-news/chemours-co-stock-hits-52week-high-at-2753-usd-93CH-4401035

Chemours Co stock hits 52-week high at 27.53 USD By Investing.com

Chemours Co (CC) stock has reached a 52-week high of $27.53, representing a 130% year-to-date return, driven by strong investor confidence and strategic growth initiatives. Despite InvestingPro's Fair Value analysis suggesting it might be overvalued, analysts predict a return to profitability and net income growth this year. Recent developments include a $700 million debt offering and an "Outperform" rating from RBC Capital due to expected improvements in titanium dioxide EBITDA margins.

https://in.investing.com/news/company-news/chemours-co-stock-hits-52week-high-at-2753-usd-93CH-5374066

How (CC) Movements Inform Risk Allocation Models

This article analyzes Chemours Company (NYSE: CC) using AI models, indicating a strong overweight bias across all time horizons despite elevated downside risk at current levels. It outlines three distinct trading strategies (Position, Momentum Breakout, Risk Hedging) with specific entry, target, and stop-loss parameters, alongside a multi-timeframe signal analysis highlighting support and resistance levels. The analysis aims to help investors optimize position sizing and minimize drawdown risk.

https://news.stocktradersdaily.com/news_release/38/How_CC_Movements_Inform_Risk_Allocation_Models_050126024402_1777617842.html

Chemours (NYSE: CC) holders back pay plan, 2026 equity plan and PwC

Chemours Company shareholders approved its 2026 Equity and Incentive Plan, reserving over 6.3 million shares for stock-based awards. Additionally, all eleven director nominees were elected, an advisory say-on-pay vote on executive compensation passed, and PricewaterhouseCoopers LLP was ratified as the independent auditor. These approvals occurred at the company's annual meeting on April 24, 2026.

https://www.stocktitan.net/sec-filings/CC/8-k-chemours-co-reports-material-event-77e109609c37.html

Chemours Shareholders Approve 2026 Equity Incentive Plan

Chemours Company shareholders approved a new 2026 Equity and Incentive Plan on April 24, 2026, authorizing over 6 million shares for stock-based awards to align incentives with shareholder interests. Investors also re-elected all directors, approved executive pay, and ratified PricewaterhouseCoopers LLP as the independent auditor. An analyst rated CC stock as a Buy with a $30.00 price target, while TipRanks’ AI Analyst, Spark, gave it a Neutral score.

https://www.tipranks.com/news/company-announcements/chemours-shareholders-approve-2026-equity-incentive-plan

Trending Today

Diamondback Energy Inc. ($FANG) Stock Forecast: Down 6.9% Today

Occidental Petroleum Corporation ($OXY) Stock Forecast: Down 5.9% Today

Cencora Inc. ($COR) Stock Forecast: Down 17.0% Today

Royal Caribbean Cruises Ltd. ($RCL) Stock Forecast: Up 6.5% Today

Valero Energy Corporation ($VLO) Stock Forecast: Down 5.0% Today

Sherwin-Williams Company (The) ($SHW) Stock Forecast: Up 5.4% Today

Freeport-McMoRan Inc. ($FCX) Stock Forecast: Up 5.7% Today

Cummins Inc. ($CMI) Stock Forecast: Up 6.1% Today

McKesson Corporation ($MCK) Stock Forecast: Down 6.0% Today

CVS Health Corporation ($CVS) Stock Forecast: Up 7.9% Today

Chemours Company (The) Price History

10.03.2026 - CC Stock was up 5.4%

• Chemours (CC) experienced a strong bullish movement today due to an increased target price and maintained Buy rating by a leading financial institution. This positive outlook reflects confidence in the company's growth potential.
• The high-performance fluoropolymers (HPF) market is projected to grow, potentially benefiting Chemours given its presence in industrial chemicals, including components for aerospace and automotive industries.
• Despite the positive forecast and price target increase, Chemours reported a negative net margin and a year-over-year revenue decline, suggesting possible challenges ahead despite the bullish market movement.
• Ongoing discussions by the EU chemicals agency regarding PFAS chemicals could have implications for Chemours in the future, underscoring regulatory risks in the industry.

30.02.2026 - CC Stock was down 5.1%

• Despite a recent 5-day winning streak and reaching a new 52-week high, Chemours stock showed strong bearish movement today.
• Investor profit-taking following the stock's surge in the past few days could explain the bearish pullback.
• Concerns from analysts regarding the company's weak operational performance, financial state, and high valuation might have influenced the bearish sentiment.
• The absence of specific positive developments today likely prompted investors to reassess their positions, resulting in the bearish market trend.

08.03.2026 - CC Stock was down 5.8%

• The bearish movement in CC's stock today could be attributed to concerns surrounding the ongoing lawsuit with the Cape Fear Public Utility Authority over PFAS contamination in drinking water.
• Despite a company raising its price target on CC and maintaining an "Outperform" rating, the market may be reacting to uncertainties regarding the impact of ultrashort-chain PFAS compounds on the company's operations.
• The upsizing and pricing of the $700 million senior notes offering by Chemours could have also influenced the bearish sentiment, as investors may be wary of the company's increased debt burden.
• The significant increase in stake by SG Americas Securities LLC signals long-term confidence in Chemours, but the market may be focusing more on the immediate challenges the company is facing with regards to environmental issues and financial decisions.

30.03.2026 - CC Stock was up 5.0%

• The significant stock price appreciation of Chemours (CC) can be attributed to multiple factors:
• Despite differing views on its valuation, the stock has experienced a surge in price, indicating investor confidence in its future.
• Investments by Vanguard Capital Management and Vanguard Portfolio Management have further bolstered faith in the company's growth.
• The recent peak in stock price reflects positive momentum and investor attraction towards Chemours.
• Concerns raised by Cumberland County about PFAS contamination pose potential risks for Chemours, potentially affecting its future stock performance.

16.03.2026 - CC Stock was up 5.1%

• Chemours (CC) reached a new 52-week high of $23.20, trading with high volume and significantly above its moving averages, reflecting robust investor interest and positive market sentiment.
• The increase in Chemours' stock price can be linked to the company's recent strong financial performance, surpassing EPS expectations, despite having certain mixed fundamentals like negative net margin and P/E ratio.
• The update about Southeast Ohio water authorities securing funds for PFAS treatment upgrades may have had a positive impact on Chemours, given the company's involvement in producing chemicals and solutions relevant for water treatment processes.
• Despite being labeled as overvalued by some analysts, there appears to be a positive market outlook on Chemours' future prospects, with institutions like UBS raising their price target and reaffirming a "Buy" rating.

26.02.2026 - CC Stock was up 5.1%

• Chemours' stock price surged by 10.11% following the completion of a successful debt swap, indicating investor confidence in the company's financial stability and growth prospects.
• The strategic agreement with SRF Limited to boost the supply of key low GWP products highlights Chemours' commitment to sustainability and meeting market demand, which likely contributed to the positive market sentiment.
• Despite facing challenges such as high debt levels and legal battles, Chemours' focus on next-generation refrigerants and environmental regulations positions it well for future growth in the chemical industry.
• The company's engagement in STEM education initiatives showcases its dedication to fostering talent and innovation, creating a positive image that resonates with investors and stakeholders.

09.03.2026 - CC Stock was up 5.6%

• CC reached a 52-week high at $22.56, marking a 139% increase in the past year, potentially attracting positivity from investors.
• Mizuho raised CC's price target to $25 from $21, upholding an "Outperform" rating, potentially enhancing investor confidence and influencing the bullish trend.
• Despite the lawsuit and regulatory challenges, CC's optimistic earnings forecast for 2026 and expected improvements in titanium dioxide EBITDA margins may have outweighed these issues, propelling the stock.
• The options chain analysis, detailing call and put options expiring in May 2026, possibly signified a bullish outlook among traders, adding momentum to CC's stock.

25.02.2026 - CC Stock was up 5.1%

• A successful $700 million debt refinancing and insider buying activities have eased financial concerns, fostering a favorable investor sentiment.
• Price target upgrades from various firms, including UBS and Mizuho, have been influenced by robust quarterly earnings within the specialized solutions segment, contributing to the uptrend in the stock.
• Despite potential challenges like regulatory scrutiny regarding environmental issues such as PFAS liabilities, Chemours' strategic outlook remains promising due to continuous innovation efforts and substantial order backlogs.
• An investigation by The Portnoy Law Firm subsequent to disappointing Q4 and full-year 2025 financial results may have initially dampened investor confidence; however, positive developments thereafter appear to have reversed the stock's trajectory.

24.02.2026 - CC Stock was up 6.1%

• The bullish movement in CC's stock can be attributed to the successful $700 million private sale of senior notes and insider buying, which helped alleviate financial concerns and boost investor confidence.
• Analyst upgrades and positive outlook on the company's strategic direction, particularly in the thermal and specialized solutions segment, have also contributed to the stock surge.
• Despite ongoing legal challenges and environmental controversies, including the lawsuit against DuPont and Chemours and opposition to the Fayetteville expansion, the market seems to be focusing more on the company-specific improvements and growth prospects, leading to the bullish momentum in CC's stock.

24.03.2026 - CC Stock was up 5.1%

• The bullish movement in CC stock today could be attributed to the positive growth outlook for the global fluoropolymer films market, driven by demand in high-performance industries like electronics and automotive.
• Earth Day petitions urging Chemours to protect the Okefenokee Swamp may have also fueled investor optimism, highlighting the company's dedication to environmental responsibility and sustainability.
• The forthcoming Q1 financial results announcement on May 5 and the subsequent public webcast on May 6 may be creating anticipation and confidence among investors, contributing to the bullish market activity in CC stock.

01.03.2026 - CC Stock was down 5.0%

• The bearish movement in Chemours stock today could be attributed to profit-taking by investors after the recent 5-day winning spree, where the stock climbed 22%.
• Concerns may have arisen among investors about potential legal liabilities and future financial impacts on the company due to the news about a potential new lawsuit against Chemours for PFAS contamination in North Carolina.
• Despite the positive collaboration with the University of Kansas on sustainable cooling technologies, the overall sentiment from analysts describing the stock as "Very Unattractive" due to weak operating performance and high valuation could have also influenced today's bearish market movement.

05.04.2026 - CC Stock was up 5.5%

• CC stock hit a new 52-week high of $27.53, marking a significant 130% year-to-date increase, driven by strong investor confidence and strategic growth measures.
• The successful $700 million debt issuance to retire existing notes and positive analyst projections regarding enhanced profitability and higher titanium dioxide EBITDA margins have further propelled the optimistic sentiment.
• Despite concerns raised about potential overvaluation, positive market sentiment, approval of equity plans by shareholders, and the appointment of an independent auditor have all played a role in the stock's upward trend.
• Strategic decisions, such as the endorsement of the 2026 Equity and Incentive Plan and favorable analyst reviews, are likely factors boosting investor confidence and contributing to the positive momentum in CC stock.